Cargando…
Metabolic liver function in humans measured by 2-(18)F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential
BACKGROUND: PET/CT with the radioactively labelled galactose analogue 2-(18)F-fluoro-2-deoxy-D-galactose ((18)F-FDGal) can be used to quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the day-to-day variation in humans with and without liver diseas...
Autores principales: | Bak-Fredslund, Kirstine P., Lykke Eriksen, Peter, Munk, Ole L., Villadsen, Gerda E., Keiding, Susanne, Sørensen, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574826/ https://www.ncbi.nlm.nih.gov/pubmed/28853060 http://dx.doi.org/10.1186/s13550-017-0320-1 |
Ejemplares similares
-
Optimal 2-[(18)F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
por: Horsager, Jacob, et al.
Publicado: (2016) -
6-Deoxy-6-fluoro-d-galactose
por: Jenkinson, Sarah F., et al.
Publicado: (2010) -
[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010) -
Human (13)N-ammonia PET studies: the importance of measuring (13)N-ammonia metabolites in blood
por: Keiding, Susanne, et al.
Publicado: (2010) -
Trypanosoma brucei UDP-galactose-4′-epimerase in ternary complex with NAD(+) and the substrate analogue UDP-4-deoxy-4-fluoro-α-d-galactose
por: Alphey, Magnus S., et al.
Publicado: (2006)